AAV9 Targets Cone Photoreceptors in the Nonhuman Primate Retina
Open Access
- 30 January 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (1) , e53463
Abstract
Transduction of retinal pigment epithelial cells with an adeno-associated viral vector (AAV) based on serotype 2 has partially corrected retinal blindness in Leber congenital amaurosis type 2. However, many applications of gene therapy for retinal blindness rely on the efficient transduction of rod and cone photoreceptor which is difficult to achieve with first generation vector technology. To address this translational need, we evaluated rod and cone photoreceptor targeting of 4 novel AAV capsids (AAV7, AAV9, rh.64R1 and rh.8R) versus AAV2 and AAV8 in a foveated retina. Eyes of 20 nonhuman primates were injected subretinally in the proximity of the fovea. While numerous vectors efficiently transduced rods, only AAV9 targeted cones both centrally and peripherally efficiently at low doses, likely due to the abundance of galactosylated glycans, the primary receptor for AAV9, on cone photoreceptors. We conclude AAV9 is an ideal candidate for strategies that require restoration of cone photoreceptor function.Keywords
This publication has 28 references indexed in Scilit:
- Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9Journal of Biological Chemistry, 2011
- AAV-mediated photoreceptor transduction of the pig cone-enriched retinaGene Therapy, 2011
- rAAV2/5 gene-targeting to rods:dose-dependent efficiency and complications associated with different promotersGene Therapy, 2010
- Achromatopsia as a Potential Candidate for Gene Therapy2009
- Gene therapy for red–green colour blindness in adult primatesNature, 2009
- Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraintsGene Therapy, 2009
- Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I TrialHuman Gene Therapy, 2008
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Novel AAV serotypes for improved ocular gene transferThe Journal of Gene Medicine, 2008